1011 — China NT Pharma Co Balance Sheet
0.000.00%
- HK$391.06m
- HK$781.04m
- CNY37.96m
Annual balance sheet for China NT Pharma Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | HKAS | HKAS | HKAS | HKAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 7.69 | 9.44 | 5.93 | 1.52 | 9.62 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 26 | 12.5 | 33.7 | 10.1 | 6.39 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 577 | 268 | 73.4 | 12.3 | 16.2 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 538 | 248 | 380 | 0.944 | 0.543 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 1,295 | 955 | 1,006 | 329 | 334 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,156 | 896 | 1,170 | 665 | 725 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 1,279 | 1,167 | 1,247 | 669 | 733 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 16.3 | -211 | -242 | -340 | -399 |
Total Liabilities & Shareholders' Equity | 1,295 | 955 | 1,006 | 329 | 334 |
Total Common Shares Outstanding |